Phosphatemic Control during Acute Renal Failure: Intermittent Hemodialysis versus Continuous Hemodiafiltration
Authors:
- 1 April 2001
- journal article
- research article
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 24 (4) , 186-191
Abstract
Background: Achieving “adequacy of dialysis” includes the maintenance of normal serum phosphate concentrations and is an important therapeutic goal in the treatment of acute renal failure (ARF). It is unknown whether this goal is best achieved with intermittent or continuous renal replacement therapy. Methods: We compared the effects of continuous veno-venous hemodiafiltration (CVVHDF) and intermittent hemodialysis (IHD) on serum phosphate concentrations using daily morning blood tests in 88 consecutive intensive care patients half of which were treated with IHD and half with CRRT. Results: Mean patient age was 54 ± 14 years for IHD and 60 ± 14 years for CVVHDF (NS). However, patients who received CVVHDF were more critically ill (mean APACHE II scores: 24.4 ± 5.1 for IHD vs. 29.2 ± 5.7 for CVVHDF, p<0.003). Before treatment, the serum phosphate concentration was 2.04 ± 0.16 mmoll L for IHD and 1.96 ± 0.17 mmoll L for CVVHDF (NS), with abnormal values in 79.4% of IHD patients and in 64.8% of CVVHDF patients (NS). During treatment, CVVHDF induced a greater reduction in serum phosphate (p=0.02) during the first 48 hours and conferred superior subsequent control of hyperphosphatemia (achieved in 64.6% of observations during CVVHDF vs. 41.8% during IHD; p<0.0001). The serum phosphate concentration was also more likely to be within the normal range during CVVHDF (55.3% vs.36.2%; p<0.0001). There was a trend toward more frequent hypophosphatemia (9.3% vs. 5.6%; P<0.1) during CVVHDF. Conclusions: Abnormal serum phosphate concentrations are frequent in ARF patients before and during renal replacement, however, normalization of phosphatemia is achieved more frequently with CVVHDF.Keywords
This publication has 22 references indexed in Scilit:
- Patient Survival and Renal Recovery in Acute Renal Failure: Randomized Comparison of Cellulose Acetate and Polysulfone Membrane DialyzersMayo Clinic Proceedings, 2000
- Disturbance of Consciousness Associated with Hypophosphatemia in a Chronically Alcoholic Patient.Internal Medicine, 1998
- Continuous renal replacement therapies versus intermittent hemodialysis in acute renal failure: What do we know?American Journal of Kidney Diseases, 1996
- High incidence of hypophosphatemia in surgical intensive care patients: Efficacy of phosphorus therapy on myocardial functionIntensive Care Medicine, 1995
- Treatment of Sepsis-Associated Severe Acute Renal Failure with Continuous Hemodiafiltration: Clinical Experience and Comparison with Conventional DialysisBlood Purification, 1995
- Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: The ODIN modelIntensive Care Medicine, 1993
- Determinants of Survival and Recovery in Acute Renal Failure Patients Dialyzed in Intensive-Care UnitsAmerican Journal of Nephrology, 1991
- APACHE IICritical Care Medicine, 1985
- Effect of Hemodialysis with Acetate vs Bicarbonate on Plasma Lipid and Lipoprotein Levels in Uremic PatientsJournal of Dialysis, 1980
- Evidence that resistance to the calcemic action of parathyroid hormone in rats with acute uremia is caused by phosphate retentionKidney International, 1979